<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62009">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01826136</url>
  </required_header>
  <id_info>
    <org_study_id>YSJeon_Acapella</org_study_id>
    <nct_id>NCT01826136</nct_id>
  </id_info>
  <brief_title>Effect of Vibratory Expiratory Pressure on Pulmonary Function After Lung Resection Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative airway clearance and recovery of pulmonary function after lung resection is
      critical in patients undergoing pulmonary resection surgery. The investigators hypothesized
      that vibratory positive expiratory pressure using the Acapella device may improve pulmonary
      function recovery in patients undergoing video-assisted thoracoscopic lung resection
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>FEV1 on the third postoperative day</measure>
    <time_frame>3 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Pulmonary Resection Surgery</condition>
  <arm_group>
    <arm_group_label>Acapella</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use of the Acapella device postoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acapella device</intervention_name>
    <arm_group_label>Acapella</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients between 20 and 65 years old

          -  undergoing video-assisted thoracoscopic lung resection surgery for suspicious lung
             cancer

          -  admission to intensive care unit in extubate state

          -  with intravenous patient-controlled analgesia

        Exclusion Criteria:

          -  body mass index of less than 15 kg/m2 or more than 30 kg/m2

          -  history of respiratory tract infection within 3 months

          -  emergency surgery

          -  preoperative supplemental oxygen or ventilator care

          -  preoperative PaO2 of less than 70 mmHg or PaCO2 of more than 50 mmHg

          -  preoperative FEV1 of less than 30% of predicted value

          -  unconsciousness or neuromuscular disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>April 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
